학술논문

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
Document Type
Article
Source
In: Blood Advances. (Blood Advances, 11 July 2023, 7(13):3192-3198)
Subject
Language
English
ISSN
24739537
24739529